The increasing knowledge in the molecular pathophysiology of non-small-cell lung cancer (NSCLC) allowed early identification of druggable targets; however, the advanced disease remains incurable mainly due to drug resistance. Therefore, it is essential to expl... ...

请注册登录后继续浏览